A Phase I/II Study of Carboplatin and TS-1 in Patients with Advanced Non-small Cell Lung Cancer: CJLSG-0402
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 21 Sep 2013
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Jan 2012 Status changed from completed to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 08 Jun 2009 New trial record.